Ettorre VM, Demirkiran C, Bellone S, Hartwich TMP, et al. Effective preclinical activity of datopotamab deruxtecan (Dato-DXd), an ADC targeting trophoblast cell-surface antigen 2 (TROP2), against primary cervical carcinoma cell lines and xenografts. Gynecol Oncol 2025;201:195-202.
PMID: 40907200